Diagnostics Company Again Named In Securities Suit Over Antibody Test Results
NEW YORK — A point-of-care diagnostics company and certain of its senior executives were hit with a second securities class action on July 3 in New York federal court, alleging that...To view the full article, register now.
Already a subscriber? Click here to view full article